These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1431710)

  • 1. Projections of cervical cancer mortality and incidence in New Zealand: the possible impact of screening.
    Cox B; Skegg DC
    J Epidemiol Community Health; 1992 Aug; 46(4):373-7. PubMed ID: 1431710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer in New Zealand: national and regional trends.
    Cox B; Borman B
    N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.
    Simonella L; Canfell K
    Cancer Causes Control; 2013 Sep; 24(9):1727-36. PubMed ID: 23832659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort.
    Taylor RJ; Morrell SL; Mamoon HA; Wain GV
    J Epidemiol Community Health; 2001 Nov; 55(11):782-8. PubMed ID: 11604432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
    Hall MT; Smith MA; Lew JB; O'Hallahan J; Fentiman G; Neal H; Sage M; Canfell K
    Gynecol Oncol; 2019 Mar; 152(3):472-479. PubMed ID: 30876491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in cervical cancer in New Zealand.
    Cox B; Skegg DC
    N Z Med J; 1986 Oct; 99(812):795-8. PubMed ID: 3466084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cervical cancer epidemic that screening has prevented in the UK.
    Peto J; Gilham C; Fletcher O; Matthews FE
    Lancet; 2004 Jul 17-23; 364(9430):249-56. PubMed ID: 15262102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Secular Trends in Cervical Cancer Mortality in China and the United States: An Age-Period-Cohort Analysis.
    Wang J; Bai Z; Wang Z; Yu C
    Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27869688
    [No Abstract]   [Full Text] [Related]  

  • 11. Cervical cancer incidence and mortality in Fiji 2003-2009.
    Kuehn R; Fong J; Taylor R; Gyaneshwar R; Carter K
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):380-6. PubMed ID: 22861663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the effects of the age-period-birth cohort on cervical cancer mortality in the Brazilian Northeast.
    Meira KC; Silva GWDS; Dos Santos J; Guimarães RM; de Souza DLB; Ribeiro GPC; Dantas ESO; Carvalho JBL; Jomar RT; Simões TC
    PLoS One; 2020; 15(2):e0226258. PubMed ID: 32074101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer mortality in New Zealand: the past and projections for the future.
    Cohen RJ; Robinson E; McRae CU
    Aust N Z J Surg; 1997 Nov; 67(11):781-4. PubMed ID: 9396994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in cervical and breast cancer in Iceland. A statistical evaluation of trends in incidence and mortality for the period 1955-1989, their relation to screening and prediction to the year 2000.
    Sigurdsson K; Adalsteinsson S; Ragnarsson J
    Int J Cancer; 1991 Jun; 48(4):523-8. PubMed ID: 2045199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in cervical cancer mortality in the Americas.
    Robles SC; White F; Peruga A
    Bull Pan Am Health Organ; 1996 Dec; 30(4):290-301. PubMed ID: 9041740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cervical cancer: recent trends of incidence and mortality in Lithuania].
    Aleknaviciene B; Smailyte G; Elaawar B; Kurtinaitis J
    Medicina (Kaunas); 2002; 38(2):223-30. PubMed ID: 12474744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.
    Vaccarella S; Franceschi S; Zaridze D; Poljak M; Veerus P; Plummer M; Bray F
    Lancet Oncol; 2016 Oct; 17(10):1445-1452. PubMed ID: 27567054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in incidence of and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994).
    Walker JJ; Brewster D; Gould A; Raab GM
    Public Health; 1998 Nov; 112(6):373-8. PubMed ID: 9883033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast and cervical cancer incidence and mortality trends in Russia 1980-2013.
    Barchuk A; Bespalov A; Huhtala H; Chimed T; Laricheva I; Belyaev A; Bray F; Anttila A; Auvinen A
    Cancer Epidemiol; 2018 Aug; 55():73-80. PubMed ID: 29843073
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.